Page 8 - Immunizations News Today

The FTSE-100 drugmaker predicted new drug and vaccine launches will see its annual sales hit £38 billion by 2031

By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the...

By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the...

GSK reports earnings Wednesday in a week week for pharmaceutical companies’ results. A large focus will be its RSV vaccine, Arexy.

It happens every year around this time: The Centers for Disease Control and Prevention releases the new years immunization schedules, which describe when and how vaccines should be given.

None of the women who had received the vaccine before age 14 years developed cervical cancer.

The organization will boost its spending to $8.6 billion this year to tackle poverty, healthcare, sustainable agriculture, and other areas where it finds...

By Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the...

The elimination of the endemic transmission of rubella in Italy prompted a reconsideration of the country’s pregnancy guidelines.

By Rob Curran Evaxion Biotech shares shot higher after the vaccine developer said it was exploring cancer vaccines using its artificial-intelligence...